GDME1223IDB - United States Wound Care Management Market … · SAMPLE United States Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices,

SAMPLE

United States Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices,

Pressure Relief Devices, Ostomy Drainage Bags and Others GDME1223IDB/ Published January 2013

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 1

United States Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others

Reference Code: GDME1223IDB

Publication Date: January 2013

SAMPLETable of Contents




1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 11

1.2 List of Figures 16

2 Introduction 20

2.1 What is This Report About? 20

3 Wound Care Management In United States 21

3.1 Wound Care Management, United States, Overall Revenue ($m), USD Constant, 2004-2018 21

3.2 Wound Care Management Market, United States, Revenue Mix ($m), 2011 23

3.3 Wound Care Management Market, United States, Category Contribution (%), 2011 24

3.4 Wound Care Management, United States, Company Share (2010-2011) 31

4 Advanced Wound Management In United States 33

4.1 Advanced Wound Management, Market Segmentation 33

4.2 Advanced Wound Management Market, United States, Revenue Mix ($m), 2011 34

4.3 Advanced Wound Management Market, United States, Segment Contribution (%), 2011 35

4.4 Advanced Wound Management Overall Revenue, (2004-2018) 36

4.4.1 Semi-Permeable Films, Revenue (2004-2018) 40

4.4.2 Foams, Revenue (2004-2018) 44

4.4.3 Hydrofibres, Revenue (2004-2018) 48

4.4.4 Hydrocolloids, Revenue (2004-2018) 52

4.4.5 Hydrogels, Revenue (2004-2018) 56

4.4.6 Alginates, Revenue (2004-2018) 60

4.4.7 Collagens, Revenue (2004-2018) 64

4.5 Advanced Wound Management Overall Volume (2004-2018) 68

4.5.1 Semi-Permeable Films, Volume (2004-2018) 72

4.5.2 Foams, Volume (2004-2018) 74

4.5.3 Hydrofibres, Volume (2004-2018) 76





4.5.4 Hydrocolloids, Volume (2004-2018) 78

4.5.5 Hydrogels, Volume (2004-2018) 80

4.5.6 Alginates, Volume (2004-2018) 82

4.5.7 Collagens, Volume (2004-2018) 84

4.6 Advanced Wound Management Average Price (2004-2018) 86

4.7 Advanced Wound Management Distribution Share (2010-2011) 88

4.8 Advanced Wound Management, United States, Company Share (2010-2011) 89

5 Automated Suturing Devices In United States 91

5.1 Automated Suturing Devices Overall Revenue, (2004-2018) 91

5.2 Automated Suturing Devices Overall Volume (2004-2018) 93

5.3 Automated Suturing Devices Average Price (2004-2018) 95

5.4 Automated Suturing Devices Distribution Share (2010-2011) 95

6 Compression Therapy In United States 96

6.1 Compression Therapy, Market Segmentation 96

6.2 Compression Therapy Market, United States, Revenue Mix ($m), 2011 97

6.3 Compression Therapy Market, United States, Segment Contribution (%), 2011 98

6.4 Compression Therapy Overall Revenue, (2004-2018) 99

6.4.1 Dynamic Compression Therapy, Revenue (2004-2018) 103

6.4.2 Static Compression Therapy, Revenue (2004-2018) 107

6.5 Compression Therapy Overall Volume (2004-2018) 111

6.5.1 Dynamic Compression Therapy, Volume (2004-2018) 113

6.5.2 Static Compression Therapy, Volume (2004-2018) 115

6.6 Compression Therapy Average Price (2004-2018) 119

6.7 Compression Therapy Distribution Share (2010-2011) 120

6.8 Compression Therapy, United States, Company Share (2010-2011) 121

7 Negative Pressure Wound Therapy (NPWT) In United States 122





7.1 Negative Pressure Wound Therapy (NPWT), Market Segmentation 122

7.2 Negative Pressure Wound Therapy (NPWT) Market, United States, Revenue Mix ($m), 2011 123

7.3 Negative Pressure Wound Therapy (NPWT) Market, United States, Segment Contribution (%),

2011 124

7.4 Negative Pressure Wound Therapy (NPWT) Overall Revenue, (2004-2018) 125

7.4.1 NPWT Sales Business, Revenue (2004-2018) 129

7.5 Negative Pressure Wound Therapy (NPWT) Sales Business Overall Volume (2004-2018) 133

7.5.1 NPWT Sales Business, Volume (2004-2018) 133

7.6 Negative Pressure Wound Therapy (NPWT) Average Price (2004-2018) 137

7.7 Negative Pressure Wound Therapy (NPWT) Distribution Share (2010-2011) 137

7.7.1 NPWT Rental Business, United States, Company Share (2010-2011) 138

7.7.2 NPWT Sales Business, United States, Company Share (2010-2011) 139

7.8 Negative Pressure Wound Therapy (NPWT), United States, Company Share (2010-2011) 140

8 Ostomy Drainage Bags In United States 142

8.1 Ostomy Drainage Bags, Market Segmentation 142

8.2 Ostomy Drainage Bags Market, United States, Revenue Mix ($m), 2011 143

8.3 Ostomy Drainage Bags Market, United States, Segment Contribution (%), 2011 144

8.4 Ostomy Drainage Bags Overall Revenue, (2004-2018) 145

8.5 Ostomy Drainage Bags Overall Volume (2004-2018) 149

8.6 Ostomy Drainage Bags Average Price (2004-2018) 152

8.7 Ostomy Drainage Bags Distribution Share (2010-2011) 153

8.8 Ostomy Drainage Bags, United States, Company Share (2010-2011) 154

9 Pressure Relief Devices In United States 155

9.1 Pressure Relief Devices, Market Segmentation 155

9.2 Pressure Relief Devices Market, United States, Revenue Mix ($m), 2011 156





9.3 Pressure Relief Devices Market, United States, Segment Contribution (%), 2011 157

9.4 Pressure Relief Devices Overall Revenue, (2004-2018) 158

9.5 Pressure Relief Devices Overall Volume (2004-2018) 162

9.6 Pressure Relief Devices Average Price (2004-2018) 164

9.7 Pressure Relief Devices Distribution Share (2010-2011) 165

9.7.1 Speciality Beds Rental Business, United States, Company Share (2010-2011) 166

9.8 Pressure Relief Devices, United States, Company Share (2010-2011) 167

10 Tissue Engineering In United States 169

10.1 Tissue Engineering, Market Segmentation 169

10.2 Tissue Engineering Market, United States, Revenue Mix ($m), 2011 170

10.3 Tissue Engineering Market, United States, Segment Contribution (%), 2011 171

10.4 Tissue Engineering Overall Revenue, (2004-2018) 172

10.5 Tissue Engineering Overall Volume (2004-2018) 176

10.6 Tissue Engineering Average Price (2004-2018) 178

10.7 Tissue Engineering Distribution Share (2010-2011) 178

11 Traditional Wound Management In United States 179

11.1 Traditional Wound Management, Market Segmentation 179

11.2 Traditional Wound Management Market, United States, Revenue Mix ($m), 2011 180

11.3 Traditional Wound Management Market, United States, Segment Contribution (%), 2011 181

11.4 Traditional Wound Management Overall Revenue, (2004-2018) 182

11.5 Traditional Wound Management Overall Volume (2004-2018) 186

11.6 Traditional Wound Management Average Price (2004-2018) 190

11.7 Traditional Wound Management Distribution Share (2010-2011) 191





11.8 Traditional Wound Management, United States, Company Share (2010-2011) 192

12 Wound Closure Devices In United States 193

12.1 Wound Closure Devices, Market Segmentation 193

12.2 Wound Closure Devices Market, United States, Revenue Mix ($m), 2011 194

12.3 Wound Closure Devices Market, United States, Segment Contribution (%), 2011 195

12.4 Wound Closure Devices Overall Revenue, (2004-2018) 196

12.4.1 Hemostats, Revenue (2004-2018) 200

12.4.2 Tissue Sealants, Revenue (2004-2018) 204

12.5 Wound Closure Devices Overall Volume (2004-2018) 208

12.5.1 Hemostats, Volume (2004-2018) 212

12.5.2 Tissue Sealants, Volume (2004-2018) 215

12.6 Wound Closure Devices Average Price (2004-2018) 217

12.7 Wound Closure Devices Distribution Share (2010-2011) 218

12.8 Wound Closure Devices, United States, Company Share (2010-2011) 219

13 Wound Debridement Devices In United States 221

13.1 Wound Debridement Devices Overall Revenue, (2004-2018) 221

13.2 Wound Debridement Devices Distribution Share (2010-2011) 223

13.3 Wound Debridement Devices, United States, Company Share (2010-2011) 224

14 Overview of Key Companies in United States Wound Care Management Market 225

14.1 Kinetic Concepts, Inc. 225

14.1.1 Company Overview 225

14.1.2 Share in the United States Wound Care Management Market 225

14.2 Covidien plc 226



14.3 Hill-Rom Holdings, Inc. 227







14.4 ConvaTec Inc. 228



14.5 Smith & Nephew Plc 229



14.6 Hollister Incorporated 230



14.7 Ethicon, Inc. 231


14.8 3M Health Care Ltd. 231


14.9 ArjoHuntleigh 231


14.10 BSN medical GmbH 232


14.11 Coloplast A/S 232


14.12 Baxter International Inc. 232


14.13 Johnson & Johnson 233


14.14 Molnlycke Health Care AB 233


14.15 Systagenix Wound Management Limited 234


14.16 B. Braun Melsungen AG 234






14.17 SIGVARIS, Inc. 235


14.18 Invacare Corporation 235


14.19 medi GmbH & Co. KG 235


14.20 Derma Sciences, Inc. 236


14.21 Talley Group Limited 236


14.22 Julius Zorn, Inc. 236


14.23 Stryker Corporation 237


14.24 Paul Hartmann AG 237


14.25 ConMed Corporation 238


14.26 Medela AG 238


15 Wound Care Management Market Pipeline Products 239

16 Financial Deals Landscape 247

16.1 Acquisition 247

16.1.1 Smith & Nephew To Acquire Healthpoint Biotherapeutics, Wound Care Company, For $782

Million 247

16.1.2 Kinetic Concepts Acquires MoMelan Technologies, Manufacturer Of Skin Graft Technology 249

16.1.3 Morrissey Group Acquires Bandages Plus, Distributor Of Compression Therapy Products 251

16.1.4 C. R. Bard To Acquire Neomend, Developer Of Wound Healing Products, For Up To $165 Million

252

16.1.5 Systagenix Acquires O2 Insights 254





16.1.6 Smith & Nephew Acquires Kalypto Medical, Maker Of Negative Pressure Wound Therapy

Devices 255

16.1.7 Derma Sciences Acquires MedEfficiency, Wound Care Management Company, For $14.5 Million

256

16.1.8 Wound Management Technologies Completes Divestment Of Secure eHealth 258

16.1.9 Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million 259

16.1.10 W.M. Barr Acquires Microban International From TA Associates 260

16.2 Partnerships 261

16.2.1 Parios Regenerative Sciences Enters Into Licensing Agreement With Brown University For

Oderm 261

16.2.2 Kane Biotech Enters Into Research Agreement With U.S. Army Institute of Surgical Research 262

16.2.3 Uluru To Enter Into Licensing Agreement With Melmed For OraDisc Technology 263

16.2.4 novoGI Enters Into Licensing Agreement With Unique Surgical Innovations 264

16.2.5 Hydromer Enters Into Co-Development Agreement With N8 Medical 265

16.2.6 novoGI Enters Into Co-Development Agreement With Christopher Paul Swain 266

16.2.7 Quick-Med Technologies Enters Into Licensing Agreement With Doris Hosiery Mills For Stay

Fresh Antimicrobial Technology 267

16.2.8 MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 268

16.2.9 Merit Medical Enters Into Distribution Agreement With Scion Cardio-Vascular For Clo-SurPlus

P.A.D. 269

17 Recent Developments 270

17.1 Strategy And Business Planning 270

17.1.1 Dec 14, 2012: ConvaTec Launches Operations In India 270

17.1.2 Dec 05, 2012: CSL Renames Its Australian Operations 270

17.1.3 Nov 28, 2012: CryoLife Opens Biotech Manufacturing Plant At Georgia Tech 271

17.1.4 Sep 28, 2012: Cook Medical Opens New €15m Distribution Center In Baesweiler, Germany 271

17.1.5 Sep 12, 2012: KCI Expands Operations In Brazil 272

17.1.6 Sep 06, 2012: Innovative Trauma Care Selects San Antonio, Texas For US Headquarters 273

17.1.7 Aug 30, 2012: Novant Health Signs Strategic Agreement With Memorial Health 273

17.1.8 Jul 12, 2012: BioElectronics Sets Up New Company For UK And German Operations 274

17.1.9 Jun 20, 2012: Healthpoint Biotherapeutics To Create New Cell Sciences Manufacturing Facility

274

17.1.10 May 15, 2012: BioLargo Forms Medical Products Subsidiary To Focus On Advanced Wound

Care 275

17.1.11 May 10, 2012: C R Bard Creates 200 New Jobs Through Puerto Rican Expansion 275

17.1.12 Mar 01, 2012: Filtrona Porous Opens New Singapore Office 276

17.1.13 Jan 09, 2012: Sharp HealthCare Secures Expanded Role In Development Of New Medicines

With Designation As Quintiles Prime Site 276





17.2 Legal and Regulatory 277

17.2.1 Nov 13, 2012: Integra LifeSciences' UK Manufacturing Facility Receives Warning Letter From

FDA 277

17.2.2 Sep 26, 2012: Wound Management Reaches Agreement In Principle With SEC 277

17.2.3 Jun 14, 2012: CryoLife Announces Settlement Of Medafor Lawsuit 277

17.2.4 Mar 16, 2012: HemCon Receives en Banc Decision From Patent Appeals Court 278

17.2.5 Feb 06, 2012: Smith & Nephew Reaches Settlement With US Government 278

17.2.6 Jan 23, 2012: Appeals Court Will Consider Patent Infringement Case En Banc: HemCon 279

17.2.7 Jan 17, 2012: Levi & Korsinsky Announces Investigation Against Integra LifeSciences 279

17.3 Government and Public Interest 279

17.3.1 Aug 06, 2012: Cytomedix Announces Medicare Coverage For Autologous PRP Gel In Chronic

Wound Care 279

17.3.2 Apr 17, 2012: Quick-Med' NIMBUS Technology Advancements To Be Presented At Symposium

On Advanced Wound Care 280

17.4 Product News 281

17.4.1 Aug 20, 2012: Innovative Therapies Holds Multi-Disciplinary Medical Forum To Discuss New

Concepts In Negative Pressure Wound Therapy 281

17.4.2 Aug 06, 2012: Cytomedix Announces Medicare Coverage For Autologous PRP Gel In Chronic

Wound Care 281

17.4.3 Feb 07, 2012: Alliqua Receives Healthcare HCPCS Code For Its Silver Based Hydrogel

Dressings 282

17.4.4 Jan 26, 2012: 90-Day Global Surgical Period Eliminated For Application Of OASIS Product Line:

Healthpoint Biotherapeutics 283

18 Appendix 284

18.1 Definitions of Markets Covered in the Report 285

18.1.1 Wound Care Management 285

18.2 Research Methodology 293

18.3 Secondary Research 293

18.4 Primary Research 294

18.5 Models 294

18.6 Forecasts 295

18.7 Expert Panels 295

18.8 GlobalData Consulting 295





18.9 Disclaimer 295

1.1 List of Tables

Table 1: Wound Care Management, United States, Overall Revenue ($m), USD Constant, 2004-2018 22

Table 2: Wound Care Management Market, United States, Category Contribution (%), 2011 24

Table 3: Wound Care Management, United States, Cross-Category Analysis,Revenue ($m), USD Constant, 2004-2018 26

Table 4: Wound Care Management, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 28

Table 5: Wound Care Management, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 30

Table 6: Wound Care Management, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 32

Table 7: Advanced Wound Management Market, United States, Segment Contribution (%), 2011 35

Table 8: Advanced Wound Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 37

Table 9: Advanced Wound Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 39

Table 10: Semi-Permeable Films, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 41

Table 11: Semi-Permeable Films, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 43

Table 12: Foams, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 45

Table 13: Foams, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 47

Table 14: Hydrofibres, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49

Table 15: Hydrofibres, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 51

Table 16: Hydrocolloids, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 53

Table 17: Hydrocolloids, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 55

Table 18: Hydrogels, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 57

Table 19: Hydrogels, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 59

Table 20: Alginates, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 61

Table 21: Alginates, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 63

Table 22: Collagens, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 65

Table 23: Collagens, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 67

Table 24: Advanced Wound Management, United States, Volume (Units) by Segment, Historic, 2004-2011 69

Table 25: Advanced Wound Management, United States, Volume (Units) by Segment, Forecast, 2011-2018 71

Table 26: Semi-Permeable Films, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 72

Table 27: Semi-Permeable Films, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 73

Table 28: Foams, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 74

Table 29: Foams, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 75

Table 30: Hydrofibres, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 76

Table 31: Hydrofibres, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 77





Table 32: Hydrocolloids, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 78

Table 33: Hydrocolloids, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 79

Table 34: Hydrogels, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 80

Table 35: Hydrogels, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 81

Table 36: Alginates, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 82

Table 37: Alginates, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 83

Table 38: Collagens, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 84

Table 39: Collagens, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 85

Table 40: Advanced Wound Management, United States, Average Price ($), Historic, 2004-2011 86

Table 41: Advanced Wound Management, United States, Average Price ($), Forecast, 2011-2018 87

Table 42: Advanced Wound Management, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 88

Table 43: Advanced Wound Management, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 90

Table 44: Automated Suturing Devices, United States, Revenue ($m) USD Constant, Historic, 2004-2011 91

Table 45: Automated Suturing Devices, United States, Revenue ($m) USD Constant, Forecast, 2011-2018 92

Table 46: Automated Suturing Devices, United States, Volume (Units), Historic, 2004-2011 93

Table 47: Automated Suturing Devices, United States, Volume (Units), Forecast, 2011-2018 94

Table 48: Automated Suturing Devices, United States, Average Price ($), Historic, 2004-2011 95

Table 49: Automated Suturing Devices, United States, Average Price ($), Forecast, 2011-2018 95

Table 50: Automated Suturing Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 95

Table 51: Compression Therapy Market, United States, Segment Contribution (%), 2011 98

Table 52: Compression Therapy, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 100

Table 53: Compression Therapy, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 102

Table 54: Dynamic Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 104

Table 55: Dynamic Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 106

Table 56: Static Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 108

Table 57: Static Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 110

Table 58: Compression Therapy, United States, Volume (Units) by Segment, Historic, 2004-2011 111

Table 59: Compression Therapy, United States, Volume (Units) by Segment, Forecast, 2011-2018 112

Table 60: Dynamic Compression Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 113

Table 61: Dynamic Compression Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 114

Table 62: Static Compression Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 116

Table 63: Static Compression Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 118

Table 64: Compression Therapy, United States, Average Price ($), Historic, 2004-2011 119

Table 65: Compression Therapy, United States, Average Price ($), Forecast, 2011-2018 119





Table 66: Compression Therapy, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 120

Table 67: Compression Therapy, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 121

Table 68: Negative Pressure Wound Therapy (NPWT) Market, United States, Segment Contribution (%), 2011 124

Table 69: Negative Pressure Wound Therapy (NPWT), United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 126

Table 70: Negative Pressure Wound Therapy (NPWT), United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 128

Table 71: NPWT Sales Business, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 130

Table 72: NPWT Sales Business, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 132

Table 73: NPWT Sales Business, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 134

Table 74: NPWT Sales Business, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 136

Table 75: Negative Pressure Wound Therapy (NPWT), United States, Average Price ($), Historic, 2004-2011 137

Table 76: Negative Pressure Wound Therapy (NPWT), United States, Average Price ($), Forecast, 2011-2018 137

Table 77: Negative Pressure Wound Therapy (NPWT), United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 137

Table 78: NPWT Rental Business, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 138

Table 79: NPWT Sales Business, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 139

Table 80: Negative Pressure Wound Therapy (NPWT), United States, Company Share by Revenue ($m), USD Constant, 2010-2011 141

Table 81: Ostomy Drainage Bags Market, United States, Segment Contribution (%), 2011 144

Table 82: Ostomy Drainage Bags, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 146

Table 83: Ostomy Drainage Bags, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 148

Table 84: Ostomy Drainage Bags, United States, Volume (Units) by Segment, Historic, 2004-2011 150

Table 85: Ostomy Drainage Bags, United States, Volume (Units) by Segment, Forecast, 2011-2018 151

Table 86: Ostomy Drainage Bags, United States, Average Price ($), Historic, 2004-2011 152

Table 87: Ostomy Drainage Bags, United States, Average Price ($), Forecast, 2011-2018 152

Table 88: Ostomy Drainage Bags, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 153

Table 89: Ostomy Drainage Bags, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 154

Table 90: Pressure Relief Devices Market, United States, Segment Contribution (%), 2011 157

Table 91: Pressure Relief Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 159

Table 92: Pressure Relief Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 161

Table 93: Pressure Relief Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 162

Table 94: Pressure Relief Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 163

Table 95: Pressure Relief Devices, United States, Average Price ($), Historic, 2004-2011 164

Table 96: Pressure Relief Devices, United States, Average Price ($), Forecast, 2011-2018 164

Table 97: Pressure Relief Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 165

Table 98: Speciality Beds Rental Business, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 166

Table 99: Pressure Relief Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 168





Table 100: Tissue Engineering Market, United States, Segment Contribution (%), 2011 171

Table 101: Tissue Engineering, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 173

Table 102: Tissue Engineering, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 175

Table 103: Tissue Engineering, United States, Volume (Units) by Segment, Historic, 2004-2011 176

Table 104: Tissue Engineering, United States, Volume (Units) by Segment, Forecast, 2011-2018 177

Table 105: Tissue Engineering, United States, Average Price ($), Historic, 2004-2011 178

Table 106: Tissue Engineering, United States, Average Price ($), Forecast, 2011-2018 178

Table 107: Tissue Engineering, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 178

Table 108: Traditional Wound Management Market, United States, Segment Contribution (%), 2011 181

Table 109: Traditional Wound Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 183

Table 110: Traditional Wound Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 185

Table 111: Traditional Wound Management, United States, Volume (Units) by Segment, Historic, 2004-2011 187

Table 112: Traditional Wound Management, United States, Volume (Units) by Segment, Forecast, 2011-2018 189

Table 113: Traditional Wound Management, United States, Average Price ($), Historic, 2004-2011 190

Table 114: Traditional Wound Management, United States, Average Price ($), Forecast, 2011-2018 190

Table 115: Traditional Wound Management, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 191

Table 116: Traditional Wound Management, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 192

Table 117: Wound Closure Devices Market, United States, Segment Contribution (%), 2011 195

Table 118: Wound Closure Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 197

Table 119: Wound Closure Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 199

Table 120: Hemostats, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 201

Table 121: Hemostats, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 203

Table 122: Tissue Sealants, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 205

Table 123: Tissue Sealants, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 207

Table 124: Wound Closure Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 209

Table 125: Wound Closure Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 211

Table 126: Hemostats, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 213

Table 127: Hemostats, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 214

Table 128: Tissue Sealants, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 215

Table 129: Tissue Sealants, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 216

Table 130: Wound Closure Devices, United States, Average Price ($), Historic, 2004-2011 217

Table 131: Wound Closure Devices, United States, Average Price ($), Forecast, 2011-2018 217

Table 132: Wound Closure Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 218

Table 133: Wound Closure Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 220





Table 134: Wound Debridement Devices, United States, Revenue ($m) USD Constant, Historic, 2004-2011 221

Table 135: Wound Debridement Devices, United States, Revenue ($m) USD Constant, Forecast, 2011-2018 222

Table 136: Wound Debridement Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011 223

Table 137: Wound Debridement Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011 224

Table 138: Wound Care ManagementMarket Pipeline Products 239

Table 139: Smith & Nephew To Acquire Healthpoint Biotherapeutics, Wound Care Company, For $782 Million 247

Table 140: Kinetic Concepts Acquires MoMelan Technologies, Manufacturer Of Skin Graft Technology 249

Table 141: Morrissey Group Acquires Bandages Plus, Distributor Of Compression Therapy Products 251

Table 142: C. R. Bard To Acquire Neomend, Developer Of Wound Healing Products, For Up To $165 Million 252

Table 143: Systagenix Acquires O2 Insights 254

Table 144: Smith & Nephew Acquires Kalypto Medical, Maker Of Negative Pressure Wound Therapy Devices 255

Table 145: Derma Sciences Acquires MedEfficiency, Wound Care Management Company, For $14.5 Million 256

Table 146: Wound Management Technologies Completes Divestment Of Secure eHealth 258

Table 147: Perrigo Acquires CanAm Care, Distributor Of Diabetes Care Products, For $36 Million 259

Table 148: W.M. Barr Acquires Microban International From TA Associates 260

Table 149: Parios Regenerative Sciences Enters Into Licensing Agreement With Brown University For Oderm 261

Table 150: Kane Biotech Enters Into Research Agreement With U.S. Army Institute of Surgical Research 262

Table 151: Uluru To Enter Into Licensing Agreement With Melmed For OraDisc Technology 263

Table 152: novoGI Enters Into Licensing Agreement With Unique Surgical Innovations 264

Table 153: Hydromer Enters Into Co-Development Agreement With N8 Medical 265

Table 154: novoGI Enters Into Co-Development Agreement With Christopher Paul Swain 266

Table 155: Quick-Med Technologies Enters Into Licensing Agreement With Doris Hosiery Mills For Stay Fresh Antimicrobial Technology 267

Table 156: MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 268

Table 157: Merit Medical Enters Into Distribution Agreement With Scion Cardio-Vascular For Clo-SurPlus P.A.D. 269





1.2 List of Figures

Figure 1: Wound Care Management, United States, Overall Revenue ($m), USD Constant, 2004-2018 21

Figure 2: Wound Care Management Market, United States, Revenue Mix ($m), 2011 23

Figure 3: Wound Care Management Market, United States, Category Contribution (%), 2011 24

Figure 4: Wound Care Management, United States, Cross-Category Analysis , 2004-2018 25

Figure 5: Wound Care Management, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011 27

Figure 6: Wound Care Management, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 29

Figure 7: Wound Care Management, United States, Company Share (%), 2011 31

Figure 8: Advanced Wound Management, Market Segmentation 33

Figure 9: Advanced Wound Management Market, United States, Revenue Mix ($m), 2011 34

Figure 10: Advanced Wound Management Market, United States, Segment Contribution (%), 2011 35

Figure 11: Advanced Wound Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 36

Figure 12: Advanced Wound Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 38

Figure 13: Semi-Permeable Films, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 40

Figure 14: Semi-Permeable Films, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 42

Figure 15: Foams, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 44

Figure 16: Foams, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 46

Figure 17: Hydrofibres, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 48

Figure 18: Hydrofibres, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 50

Figure 19: Hydrocolloids, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 52

Figure 20: Hydrocolloids, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 54

Figure 21: Hydrogels, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 56

Figure 22: Hydrogels, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 58

Figure 23: Alginates, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 60

Figure 24: Alginates, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 62

Figure 25: Collagens, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 64

Figure 26: Collagens, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 66

Figure 27: Advanced Wound Management, United States, Volume (Units) by Segment, Historic, 2004-2011 68

Figure 28: Advanced Wound Management, United States, Volume (Units) by Segment, Forecast, 2011-2018 70

Figure 29: Semi-Permeable Films, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 72

Figure 30: Semi-Permeable Films, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 73

Figure 31: Foams, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 74

Figure 32: Foams, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 75

Figure 33: Hydrofibres, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 76

Figure 34: Hydrofibres, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 77





Figure 35: Hydrocolloids, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 78

Figure 36: Hydrocolloids, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 79

Figure 37: Hydrogels, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 80

Figure 38: Hydrogels, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 81

Figure 39: Alginates, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 82

Figure 40: Alginates, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 83

Figure 41: Collagens, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 84

Figure 42: Collagens, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 85

Figure 43: Advanced Wound Management, United States, Company Share (%), 2011 89

Figure 44: Automated Suturing Devices, United States, Revenue ($m) USD Constant, Historic, 2004-2011 91

Figure 45: Automated Suturing Devices, United States, Revenue ($m) USD Constant, Forecast, 2011-2018 92

Figure 46: Automated Suturing Devices, United States, Volume (Units), Historic, 2004-2011 93

Figure 47: Automated Suturing Devices, United States, Volume (Units), Forecast, 2011-2018 94

Figure 48: Compression Therapy, Market Segmentation 96

Figure 49: Compression Therapy Market, United States, Revenue Mix ($m), 2011 97

Figure 50: Compression Therapy Market, United States, Segment Contribution (%), 2011 98

Figure 51: Compression Therapy, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 99

Figure 52: Compression Therapy, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 101

Figure 53: Dynamic Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 103

Figure 54: Dynamic Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 105

Figure 55: Static Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 107

Figure 56: Static Compression Therapy, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 109

Figure 57: Compression Therapy, United States, Volume (Units) by Segment, Historic, 2004-2011 111

Figure 58: Compression Therapy, United States, Volume (Units) by Segment, Forecast, 2011-2018 112

Figure 59: Dynamic Compression Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 113

Figure 60: Dynamic Compression Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 114

Figure 61: Static Compression Therapy, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 115

Figure 62: Static Compression Therapy, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 117

Figure 63: Compression Therapy, United States, Company Share (%), 2011 121

Figure 64: Negative Pressure Wound Therapy (NPWT), Market Segmentation 122

Figure 65: Negative Pressure Wound Therapy (NPWT) Market, United States, Revenue Mix ($m), 2011 123

Figure 66: Negative Pressure Wound Therapy (NPWT) Market, United States, Segment Contribution (%), 2011 124

Figure 67: Negative Pressure Wound Therapy (NPWT), United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 125

Figure 68: Negative Pressure Wound Therapy (NPWT), United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 127





Figure 69: NPWT Sales Business, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 129

Figure 70: NPWT Sales Business, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 131

Figure 71: NPWT Sales Business, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 133

Figure 72: NPWT Sales Business, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 135

Figure 73: NPWT Rental Business, United States, Company Share (%), 2011 138

Figure 74: NPWT Sales Business, United States, Company Share (%), 2011 139

Figure 75: Negative Pressure Wound Therapy (NPWT), United States, Company Share (%), 2011 140

Figure 76: Ostomy Drainage Bags, Market Segmentation 142

Figure 77: Ostomy Drainage Bags Market, United States, Revenue Mix ($m), 2011 143

Figure 78: Ostomy Drainage Bags Market, United States, Segment Contribution (%), 2011 144

Figure 79: Ostomy Drainage Bags, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 145

Figure 80: Ostomy Drainage Bags, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 147

Figure 81: Ostomy Drainage Bags, United States, Volume (Units) by Segment, Historic, 2004-2011 149

Figure 82: Ostomy Drainage Bags, United States, Volume (Units) by Segment, Forecast, 2011-2018 151

Figure 83: Ostomy Drainage Bags, United States, Company Share (%), 2011 154

Figure 84: Pressure Relief Devices, Market Segmentation 155

Figure 85: Pressure Relief Devices Market, United States, Revenue Mix ($m), 2011 156

Figure 86: Pressure Relief Devices Market, United States, Segment Contribution (%), 2011 157

Figure 87: Pressure Relief Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 158

Figure 88: Pressure Relief Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 160

Figure 89: Pressure Relief Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 162

Figure 90: Pressure Relief Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 163

Figure 91: Speciality Beds Rental Business, United States, Company Share (%), 2011 166

Figure 92: Pressure Relief Devices, United States, Company Share (%), 2011 167

Figure 93: Tissue Engineering, Market Segmentation 169

Figure 94: Tissue Engineering Market, United States, Revenue Mix ($m), 2011 170

Figure 95: Tissue Engineering Market, United States, Segment Contribution (%), 2011 171

Figure 96: Tissue Engineering, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 172

Figure 97: Tissue Engineering, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 174

Figure 98: Tissue Engineering, United States, Volume (Units) by Segment, Historic, 2004-2011 176

Figure 99: Tissue Engineering, United States, Volume (Units) by Segment, Forecast, 2011-2018 177

Figure 100: Traditional Wound Management, Market Segmentation 179

Figure 101: Traditional Wound Management Market, United States, Revenue Mix ($m), 2011 180

Figure 102: Traditional Wound Management Market, United States, Segment Contribution (%), 2011 181

Figure 103: Traditional Wound Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 182





Figure 104: Traditional Wound Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 184

Figure 105: Traditional Wound Management, United States, Volume (Units) by Segment, Historic, 2004-2011 186

Figure 106: Traditional Wound Management, United States, Volume (Units) by Segment, Forecast, 2011-2018 188

Figure 107: Traditional Wound Management, United States, Company Share (%), 2011 192

Figure 108: Wound Closure Devices, Market Segmentation 193

Figure 109: Wound Closure Devices Market, United States, Revenue Mix ($m), 2011 194

Figure 110: Wound Closure Devices Market, United States, Segment Contribution (%), 2011 195

Figure 111: Wound Closure Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 196

Figure 112: Wound Closure Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 198

Figure 113: Hemostats, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 200

Figure 114: Hemostats, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 202

Figure 115: Tissue Sealants, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 204

Figure 116: Tissue Sealants, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 206

Figure 117: Wound Closure Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 208

Figure 118: Wound Closure Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 210

Figure 119: Hemostats, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 212

Figure 120: Hemostats, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 214

Figure 121: Tissue Sealants, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 215

Figure 122: Tissue Sealants, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 216

Figure 123: Wound Closure Devices, United States, Company Share (%), 2011 219

Figure 124: Wound Debridement Devices, United States, Revenue ($m) USD Constant, Historic, 2004-2011 221

Figure 125: Wound Debridement Devices, United States, Revenue ($m) USD Constant, Forecast, 2011-2018 222

Figure 126: Wound Debridement Devices, United States, Company Share (%), 2011 224

Figure 127: Kinetic Concepts, Inc., Company Share (%),United States Wound Care Management Market, 2011 225

Figure 128: Covidien plc, Company Share (%),United States Wound Care Management Market, 2011 226

Figure 129: Hill-Rom Holdings, Inc., Company Share (%),United States Wound Care Management Market, 2011 227

Figure 130: ConvaTec Inc., Company Share (%),United States Wound Care Management Market, 2011 228

Figure 131: Smith & Nephew Plc, Company Share (%),United States Wound Care Management Market, 2011 229

Figure 132: Hollister Incorporated, Company Share (%),United States Wound Care Management Market, 2011 230

SAMPLEIntroduction




2 Introduction

GlobalData’s medical equipment market reports are the ideal guide for anyone wishing to

understand the market better in terms of revenue, unit sales, distribution shares and company

shares.

2.1 What is This Report About?

United States wound care management market report provides the following information:

1. Comprehensive data related to the market revenue, unit sales, average price, distribution

shares and company shares.

2. Global corporate-level profiles of key companies operating in the wound care management

market in United States, which includes a brief overview of the company. The selection of

the companies is based on their operational presence in United States. It includes key

multinationals as well as key local players.

3. A list of key products under development by different companies. The selection of this list

is based on the territory in which these products are being clinically investigated.

SAMPLEWound Care Management in United States




3 Wound Care Management In United States

3.1 Wound Care Management, United States, Overall Revenue ($m), USD Constant, 2004-2018

Figure 1: Wound Care Management, United States, Overall Revenue ($m), USD Constant, 2004-

2018

Source: GlobalData





Table 1: Wound Care Management, United States, Overall Revenue ($m), USD Constant, 2004-2018

Category 2004 2011 2018 CAGR 04-11 CAGR 11-18 CAGR 04-18

Negative Pressure Wound Therapy (NPWT)

Wound Closure Devices

Pressure Relief Devices

Traditional Wound Management

Compression Therapy

Advanced Wound Management

Ostomy Drainage Bags

Tissue Engineering

Wound Debridement Devices

Automated Suturing Devices

Total

Source: GlobalData





3.2 Wound Care Management Market, United States, Revenue Mix ($m), 2011

Figure 2: Wound Care Management Market, United States, Revenue Mix ($m), 2011

Source: GlobalData





3.3 Wound Care Management Market, United States, Category Contribution (%), 2011

Figure 3: Wound Care Management Market, United States, Category Contribution (%), 2011

Source: GlobalData

Table 2: Wound Care Management Market, United States, Category Contribution (%), 2011

Category Revenue ($m) Contributon Revenue (%) Contributon

Negative Pressure Wound Therapy (NPWT)

Wound Closure Devices

Pressure Relief Devices

Traditional Wound Management

Compression Therapy

Advanced Wound Management

Ostomy Drainage Bags

Tissue Engineering

Wound Debridement Devices

Automated Suturing Devices

Source: GlobalData

SAMPLEAppendix




18 Appendix

The data and analysis within this report is driven by Medical eTrack

Medical eTrack gives you the key information to drive sales, investment and deal making activity in

your business. It includes the following information:

15,000+ Market size data tables across 740 medical equipment segments and 39 countries with

historic data from 2004 forecast to 2018

6,000+ Primary expert interviews conducted per annum for ensuring data and report quality

1,100+ Conferences on medical equipment covered

1,000+ Industry leading reports per annum covering growing sectors, market trends, investment

opportunities and competitive landscape

600+ Analysis reports covering market and pipeline product analysis reports by indication, medical

equipment trends and issue reports and investment and M&A trend reports worth over $3 Million

43,000+ Medical equipment companies profiled

1,500+ Private, emerging and technology start-up company profiles

1,500+ Medical equipment manufacturers in China and India

1,500+ Medical equipment companies in Japan

700+ Companies with revenue splits and market shares by category

1,500+ Quarterly and annual medical equipment company financials

700+ Medical equipment company SWOT’s

9,000+ Pipeline product profiles

8,000+ Marketed product profiles

14,000+ Clinical trials

15,000+ Trial investigators

13,000+ New product patents

3,300+ Companies with products in development

17,000+ Deals in the medical equipment industry

1,100+ Surgical and diagnostic procedures by therapy area

40+ Key healthcare indicators by country

SAMPLEAppendix




18.1 Definitions of Markets Covered in the Report

18.1.1 Wound Care Management

The wound care management market comprises of dressings, equipment and other aids to

prevent, treat wounds and also quicken or promote wound healing. The wound care management

market covers traditional wound management, advanced wound management, Negative Pressure

Wound Therapy (NPWT), wound closure devices, ostomy drainage bags, pressure relief devices,

compression therapy, tissue engineering and automated suturing devices.

18.1.1.1 Advanced Wound Management

Advanced wound management involves use of dressing products combined with drug formulations

to provide enhanced healing properties. These dressings provide a moist and active dressings

environment for optimum healing. Active dressings are based on biomaterials such as collagens.

Similarly, moist dressings include materials such as hydrogels. This category includes semi-

permeable films, foams, hydrofibres, hydrocolloids, hydrogels, alginates, collagens and wound

contact layer dressings.

Alginates

This dressing includes alginates derived from the naturally occurring calcium and sodium salt of

alginic acid produced by a family of brown seaweed (Phaeophyceae). Alginate dressing forms a

moist gel in the presence of wound exudates. Alginate dressings fall into two kinds: those

containing 100% calcium alginate and those that contain a combination of calcium with sodium

alginate, usually in a ratio of 80:20. Both types are covered. One unit refers to pack of 10 Alginate

dressings.

Antimicrobial Alginate Dressings

These alginates dressing are impregnated with an agent that inhibits microbial growth. One unit

refers to pack of 10 alginate dressings.

Non Antimicrobial Alginate Dressings

These alginate based dressings do not have antimicrobial activity due to absence of anti microbial

agents. One unit refers to pack of 10 alginate dressings.

Collagens

This segment includes dressings that are typically made up of a combination of animal collagen

and any other formulation (such as cellulose or alginates) for structural integrity and sodium or

calcium ions. These are available in many forms (sheets, gels, pads, particles and pastes) but only

sheets and pads are tracked within this segment. One unit refers to a pack of 10 collagen

dressings.

SAMPLEAppendix




Antimicrobial Collagen Dressings

The collagen dressings are impregnated with an agent that inhibits microbial growth. One unit

refers to pack of 10 collagen dressings.

Non Antimicrobial Collagen Dressings

These are collagen based dressings lacking any type of antimicrobial agent. One unit refers to a

pack of 10 collagen dressings.

Foams

Foam dressings are made up of either a hydrophilic polyurethane or silicon foam matrix for

moisture control in wounds. Polyurethane foams consist of a hydrophilic wound contact surface

and a hydrophobic backing, which makes them highly absorbent. One unit refers to pack of 10

films.

Antimicrobial Foam Dressings

Foams impregnated with an agent which inhibits microbial growth. One unit refers to a pack of 10

foam dressings.

Non Antimicrobial Foam Dressings

These are foam based dressings that do not contain any antimicrobial agent. One unit refers to a

pack of 10 foam dressings.

Hydrocolloids

A flat, waterproof, occlusive dressing that consists of a mixture of pectins, gelatins, sodium

carboxymethylcellulose and elastomers. This dressing forms a gel on the wound surface,

promoting moist wound healing. Only self-adhesive pads are tracked within this segment. One unit

refers to a pack of 10 hydrocolloid dressings.

Antimicrobial Hydrocolloid Dressings

The hydrocolloid dressing impregnated with an agent which inhibits microbial growth. One unit

refers to a pack of 10 hydrocolloid dressings.

Non Antimicrobial Hydrocolloid Dressings

These hydrocolloid dressings are devoid of anti microbial agents and have no impact on microbial

growth. One unit refers to a pack of 10 hydrocolloid dressings.

Hydrofibres

Hydrofibres are hydrophilic, non-woven sheets or ribbon dressings composed of sodium

carboxymethylcellulose (CMC). On contact with exudates, fibers are converted from a dry dressing

to a soft coherent gel sheet, making them suitable for wounds with large amount of exudates. One

unit refers to a pack of 10 hydrofibre dressings.

SAMPLEAppendix




Antimicrobial Hydrofibre Dressings

These hydrofibre dressing are impregnated with an agent that inhibits microbial growth. One unit

refers to a pack of 10 hydrofibre dressings.

Non Antimicrobial Hydrofibre Dressings

These are hydrofibre dressings lacking antimicrobial activity due to absence of anti microbial

agents. One unit refers to a pack of 10 hydrofibre dressings.

Hydrogels

Hydrogels consist of 96% water with a matrix of insoluble polymers embedded in it. The former

helps maintain a moist wound environment while the latter facilitates absorption of wound

exudates. One unit refers to a pack of 10 dressings.

Antimicrobial Hydrogel Dressings

This type of hydrogel dressing is impregnated with an agent that inhibits microbial growth. One unit

refers to a pack of 10 hydrogel dressings.

Non Antimicrobial Hydrogel Dressings

These are hydrogel dressings lacking antimicrobial activity due to absence of anti microbial

agents. One unit refers to a pack of 10 hydrogel dressings.

Semi-Permeable Films

Semi-Permeable films are sterile plastic sheets of polyurethane coated with hypoallergenic acrylic

adhesive, used to protect shallow, minor wounds from dirt, fluid and bacteria. One unit refers to a

pack of 10 semi-permeable films.

Antimicrobial Film Dressings

These semi-permeable films are impregnated with an agent that inhibits microbial growth. One unit

refers to a pack of 10 semi-permeable films.

Non Antimicrobial Film Dressings

These are semi-permeable film dressings lacking antimicrobial activity due to absence of anti

microbial agents. One unit refers to a pack of 10 semi-permeable films.

Wound Contact Layers

A wound contact layer is ideal for use on wounds with fragile surrounding skin because it is non-

adherent and incredibly gentle on the skin. This dressing ensures a moist wound environment

while protecting the sensitive granulated wound bed. One unit refers to a pack of 10 dressings.

18.1.1.2 Automated Suturing Devices

An automated suturing device automatically stitches the adjoining tissue layer edges by repeatedly

passing a needle and the attached thread without the need of manual intervention. One unit refers

to a single device.

SAMPLEAppendix




18.1.1.3 Compression Therapy

Compression therapy involves static compression devices such as compression bandages, ready-

to-wear legwear, anti embolism stockings, diabetic shoes and dynamic compression devices such

as intermittent pumps and segmental/sequential pumps to treat vascular diseases such as venous

ulcers.

Dynamic Compression Therapy

Dynamic compression is mechanical compression applied by a mechanical pumping device

(pumps and sleeves). The pressure is applied starting from the foot proceeding towards the lower

leg and ending just below the knee.

Intermittent Pumps

Intermittent pumps provide compression therapy by compressing and decompressing the leg. The

pump inflates and deflates the sleeve in one motion and with uniform pressure along the sleeve.

One unit refers to a single pump.

Segmental/Sequential Pumps

Segmental pumps use a multi-chambered garment, that is filled sequentially, to, provide

compression therapy by compressing and decompressing the leg. The pressure applied on the

segments of the sleeves is uniform but the segments are deflated and inflated individually. One

unit refers to a single pump.

Static Compression Therapy

Static compression therapy involves application of graduated pressure starting from the ankle, up

the lower leg and ending below the knee. The distal portion of the bandage applies greater

pressure and the pressure decreases gradually towards the proximal portion of the bandage.

Generally the pressure averages between 30 mmHg and 40 mmHg. The exact pressure varies

according to the type of garments or stockings used. Static compression therapy devices are

segmented into ready-to-wear legwear, anti embolism stockings, diabetic shoes and compression

bandages.

Anti Embolism Stockings

Anti-embolism stockings are designed for bed bound patients to help prevent blood from pooling in

the veins of the leg leading to blood clots. These stockings are apt for short duration of wear during

hospitalization to deliver gradient compression ranging from 12 to 20 mmHg. These stockings are

normally available only in white and have an opening on the underside of the toes which can be

uncomfortable while walking. One unit refers to a pair of anti embolism stockings.

Compression Bandages

Compression bandages involve deliberate application of pressure to treat venous disorders of the

lower limbs like edema and swelling. Based on the level of compression produced, compression

bandages have been classified as light compression bandages, moderate compression bandages,

SAMPLEAppendix




high compression bandages and extra-high performance compression bandages. 1 unit = 1 Roll of

4x10 Yards.

Diabetic Shoes

Diabetic shoes are specifically designed therapeutic shoes which are wider and deeper than a

regular shoe. These reduce the risk of foot injuries or skin breakdown in patients suffering from

diabetes. One unit refers to a pair of diabetic shoes.

Ready-to-Wear Legwear

Ready-to-wear legwear are exceptionally durable and comfortable and provide low to medium

level of compression that ensures continuous blood flow throughout the veins. These are typically

prescribed by a medical practitioner or an extended care facility to patients after discharge from

hospital. These can be worn comfortably for long duration of time. One unit refers to a pair of

ready-to-wear legwear.

18.1.1.4 Negative Pressure Wound Therapy (NPWT)

Negative Pressure Wound Therapy (NPWT) involves the use of sub-atmospheric pressure to

enhance wound healing, or remove exudate from a wound. Revenues from sales and rent of

NPWT equipment and sales of NPWT disposables have been considered in this category.

NPWT Rental Business

Revenue generated from rent of NPWT equipment to consumers, healthcare facilities like acute

care hospitals and extended care hospitals have been covered here.

NPWT Sales Business

Revenue generated from sale of NPWT equipment to consumers, healthcare facilities like acute

care hospitals and extended care hospitals have been covered here.

NPWT Disposables

NPWT disposables are consumables used with NPWT equipment. It includes canister, dressing

and tubing. One unit is equal to one disposable kit.

NPWT Equipment

It is a non-invasive system that creates and delivers a negative pressure at the wound site

enhancing the vascularity and oxygen content of the wound. A tube decompresses a foam

dressing, continuously or intermittently to remove the exudates from a wound. One unit refers to

single equipment.

18.1.1.5 Ostomy Drainage Bags

Ostomy drainage bags are used for collection of waste fluids from the stomach through an artificial

opening created through a surgical procedure called ostomy. Ostomy devices such as ostomy

pouches and related accessories are covered under this category.

SAMPLEAppendix




Colostomy

After a colostomy procedure, a part of the colon is attached to the anterior abdominal wall, leaving

a stoma in its place and a colostomy bag/ pouch is attached to the stoma to get rid of fecal matter.

There are various types of pouches: open ended, close ended or one piece (in which the skin

adhesive is attached with it and the pouch with the skin adhesive is considered as a unit). One unit

refers to a pack of 10 bags.

Ileostomy

Ileostomy bags are usually located above the groin towards the right hand side and are used for

disposal of body matter from a stoma in the abdomen. These can be either temporary or

permanent. One unit refers to a pack of 10 bags.

Urostomy

Urostomy bags are used to collect urine after a urostomy procedure. Most urostomy bags/pouches

have an anti-reflux valve to stop back-flow in to the system. These can be either temporary or

permanent. One unit refers to a pack of 10 bags.

18.1.1.6 Pressure Relief Devices

Pressure relief devices include devices that provide a conforming support surface and distribute

body weight over a large area. Revenues from sales and rent of speciality beds and sales of

mattresses replacement made of foam, air, gel or fluid; and mattresses overlay made of foam, gel

or air are included under this category.

Mattress Overlays

An additional support surface designed to be placed directly on an existing mattress. Mattress

overlays filled with foam, gel or air are covered under this segment. One unit refers to a single

mattress overlay.

Mattresses

Mattress replacement is a support surface that totally replaces the standard mattress for pressure

ulcer management. Standard foam mattresses, alternative foam mattresses, gel filled mattresses,

air filled mattresses and fluid filled mattresses are covered under this segment. One unit refers to a

single mattress.

Speciality Beds Rental Business

Revenue generated from rent of speciality beds to consumers, healthcare facilities like acute care

hospitals and extended care hospitals has been covered here.

Speciality Beds Sales Business

This includes motor driven turning or tilting beds that aid in manual repositioning of the patient

suffering from different medical conditions. One unit refers to a single bed.

SAMPLEAppendix




18.1.1.7 Tissue Engineering

Tissue engineering for wound care management is the use of mechanical and chemical

processing of materials to manufacture products that may substitute or replace all or some

components that make up a normal skin (e.g. epidermis and/or dermis, cells and matrix). They can

be bi-layered, acellular or cellular, synthetic or biological and may consist of a synthetic epidermis

and a collagen-based dermis to encourage formation of new tissue. In products that have a

synthetic epidermis, this may act as a temporary wound covering. This category covers all types of

skin substitutes mentioned above. This category consists of Xenografts and Allografts.

Bio-engineered Allografts

Bio-engineered allografts or allografts are the transplanted cells or tissues sourced from a

genetically non-identical member of the same species. These undergo various processes to

remove the cells and deactivate or destroy pathogens. These are typically available in the form of

surgical grafts or matrix. Allografts used for both permanent and temporary application are

considered here. One unit of bio-engineered allografts refers to 100 sq. cm.

Bio-engineered Xenografts

Bio-engineered xenografts or xenografts are derived from animal sources. The tissue material is

processed to remove the cells. The products derived may consist of tissue scaffold or may be

combined with synthetic material to create a composite product. Both biological and biosynthetic

xenografts, having either permanent or temporary application, are tracked under this segment.

One unit of bio-engineered xenografts refers to 100 sq. cm.

18.1.1.8 Traditional Wound Management

Traditional wound management comprises the traditional devices like gauzes, sponges and

bandages.

Bandages

A bandage is a portion of material which provides body support. It also serves to support a medical

device like a dressing or splint. Compression bandages are not included here. One unit refers to a

pack of 50 Bandages.

Gauzes

Gauzes are translucent cotton dressings used for dressing wounds while ensuring minimal

adhesion. Rolls of gauze have been included. One unit refers to a pack of 50.

Sponges

Sponges are used to absorb body fluids and provide protection from dirt and bacteria. ABD pads,

Non Adherent dressings, gauze fluff rolls and self adhering foam, both sterile and non sterile ones,

are included here. One unit refers to a pack of 50.

SAMPLEAppendix




18.1.1.9 Wound Closure Devices

Wound closure devices are used to close wounds that occur due to injuries or surgical procedures.

This category includes hemostats, tissue sealants, mechanical stapling devices, ligating clips and

wound closure strips.

Hemostats

Hemostats are used to improve haemostasis and promote wound healing after a surgical

procedure. They contain fibrinogen, thrombin and other plasma proteins which helps promote

clotting, formation and cross-linking of fibrin. Only hemostats in the form of matrix and gauze are

included. One unit refers to a pack of 10.

Collagen Based Hemostats

Collagen based hemostats are composed of resorbable microfibrillar collagen. They attract

platelets thereby promoting the formation of a blood clot when they come into contact with blood.

Only hemostats in the form of matrix and gauze are included. One unit refers to a pack of 10.

Oxidized Regenerated Cellulose Based Hemostats

Oxidized regenerated cellulose based hemostats are poly anions having polyanhydroglucuronic

acid as a functional unit which aids platelets to commence the adhesion and aggregation process

leading to coagulation. Only hemostats in the form of matrix and gauze are included. One unit

refers to a pack of 10.

Thrombin Based Hemostats

Thrombin based hemostat transforms fibrinogen into fibrin, activates factor XIII and promotes

stabilization of the clot formed by fibrin and other proteins. Only hemostats in the form of matrix

and gauze are included. One unit refers to a pack of 10.

Ligating Clips

Ligating clips are made up of titanium and conventionally used for clamping tissues as needed

during various procedures. One unit refers to one cartridge containing 6 ligating clips.

Mechanical Stapling Devices

Mechanical stapling devices are hand held wound closure devices used to fix the staples after

surgery. This includes stapling equipment and staples. These devices may either be disposable or

reusable. One unit refers to one stapling device.

Tissue Sealants

Tissue sealant is a type of surgical tissue adhesive that is used to control bleeding during surgery.

This category includes internal sealants and external sealants.

External Sealants

External sealants are the synthetic sealants which bind covalently to tissue surface proteins.

External sealants consist of cyanoacrylate glue and polyethylene glycol hydrogels. One unit of

external sealants refers to 5 ml vial.

SAMPLEAppendix




Internal Sealants

Internal sealants are the tissue adhesives which assist in the process of coagulation by delivering

fibrinogen to the affected area. Internal sealants consist of fibrin sealants consists of fibrin

sealants and protein sealants. One unit of internal sealants refers to 5 ml vial.

Wound Closure Strips

Wound closure strips are adhesive strip-like bandages that aid in sealing wounds of the skin thus

eliminating the requirement of surface stitches or staples. One unit refers to a pack of 50 strips.

18.1.1.10 Wound Debridement Devices

Wound debridement devices are used for cleansing of wounds and elimination of devitalized tissue

to enhance wound healing. Ultrasonic and hydrotherapy devices have been tracked here. Scalpels

and curettes are not included. One unit refers to a single device.

Note: 1). Value, distribution and company shares figures reflect annual gross sales of wound care

management in local currency converted to $ at constant rate. Volume figures reflect the annual

unit sales of wound care management. The annual growth (year on year growth) and compounded

annual growth rate (CAGR) in tables is rounded off to one decimal place.

2). Company share data represents market share (in revenues and as percentage to total market)

of companies in market categories and geographies tracked. The data is rounded off to the

nearest decimal places.

18.2 Research Methodology

GlobalData’s dedicated research and analysis teams consists of qualified professionals with

experience in marketing, market research, consulting background in the medical devices industry

and advanced statistical expertise.

GlobalData adheres to the codes of practice of the Market Research Society (www.mrs.org.uk) and

the Strategic and Competitive Intelligence Professionals (www.scip.org).

All GlobalData databases are continuously updated and revised. The following research

methodology is followed for all databases and reports.

18.3 Secondary Research

The research process begins with exhaustive secondary research on internal and external sources

being carried out to source qualitative and quantitative information relating to each market.

The secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations

and SEC filings;

Industry trade journals, scientific journals and other technical literature;

Internal and external proprietary databases;

SAMPLEAppendix




Relevant patent and regulatory databases;

National government documents, statistical databases and market reports;

Procedure registries; and

News articles, press releases and web-casts specific to the companies operating in the

market.

18.4 Primary Research

GlobalData conducts thousands of interviews a year with industry participants and commentators

in order to validate its data and analysis. A typical research interview fulfills the following functions:

It provides first-hand information on market size, market trends, growth trends, competitive

landscape and future outlook;

Helps in validating and strengthening the secondary research findings; and

Further develops the analysis team’s expertise and market understanding.

Primary research involves e-mail interactions and telephonic interviews for each market, category,

segment and sub-segment across geographies.

The participants who typically take part in such a process include, but are not limited to:

Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers

and national sales managers;

Hospital stores, laboratories, pharmacies, distributors and paramedics;

Outside experts: investment bankers, valuation experts, research analysts specializing in

specific medical equipment markets; and

Key opinion leaders: physicians and surgeons specializing in different therapeutic areas

corresponding to different kinds of medical equipment.

18.5 Models

Where no hard data is available, GlobalData uses modeling and estimates in order to produce

comprehensive data sets. The following rigorous methodology is adopted:

Available hard data is cross-referenced with the following data types to produce estimates:

Demographic data on population segments;

Macro-economic indicators such as GDP, inflation rate;

Healthcare indicators such as health expenditure, physician base, healthcare infrastructure

and facilities; and

Selected epidemiological and procedure statistics.

Data is then cross-checked by the expert panel. All data and assumptions related to modeling

are stored and are made available to clients on request.

SAMPLEAppendix




18.6 Forecasts

GlobalData uses proprietary forecast models. The following four factors are utilized in the forecast

models:

Historic growth rates;

Macro-indicators such as population trends and healthcare spending;

Forecast epidemiological data; and

Qualitative trend information and assumptions.

The data is then cross-checked by the expert panel.

18.7 Expert Panels

GlobalData uses a panel of experts to cross-verify its databases and forecasts.

GlobalData’s expert panel comprises marketing managers, product specialists, international sales

managers from medical device companies; academics from research universities, KOLs from

hospitals, consultants from venture capital funds and distributors/suppliers of medical equipment

and supplies etc.

Historic data and forecasts are relayed to GlobalData’s expert panel for feedback and adjusted in

accordance with their feedback.

18.8 GlobalData Consulting

We hope that the data and analysis in this brief will help you make informed and imaginative

business decisions. If you have further requirements, GlobalData’s consulting team may be able to

help you. GlobalData offers tailor-made analytical and advisory services to drive your key strategic

decisions. For more information about GlobalData’s consulting capabilities.

18.9 Disclaimer

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any

form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior

permission of the publisher, GlobalData.

Documents

GDME1223IDB - United States Wound Care Management Market … · SAMPLE United States Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices,